Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review
Journal of the Endocrine Society · 01.08.2026 · 10 (9)
DOI: 10.1210/jendso/bvag178 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of the Endocrine Society, online erschienen am 05.08.2026. Verfasst von Kalyan Mansukhbhai Shekhda und 23 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London NW3 2QG, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pancreatic neuroendocrine tumors (pNETs) are a recognized feature of tuberous sclerosis complex (TSC). The current evidence suggests that pNETs occurring in TSC may exhibit a different clinical course from sporadic cases, but their natural history remains poorly characterized.
Objective
This study aimed to characterize the demographics, clinical presentation, management, and long-term outcomes of TSC-associated-pNETs and to propose possible guidelines for surveillance and management. Materials and Methods We conducted a multicenter retrospective review of TSC-pNET patients from 6 UK TSC specialist clinics and from 3 NET referral centers, from 2008 to 2024. Data on demographics, tumor characteristics, management, and outcomes, were collected. A systematic review of the literature from 2009 to 2026 on TSC-pNETs was also performed.
Results
We identified a total of 26 consecutive cases with the TSC-pNET-association in our cohort: 21 cases of pNETs from TSC specialist clinics (1.1% of the population), and 5 cases of TSC-pNETs from the NET referral centers (0.25% of the population). An additional 80 cases were identified from the published literature. We observed a wide spectrum of clinical phenotypes, with the majority being nonfunctioning pNETs (n = 24; 92%), whereas 2 patients were diagnosed with glucagonomas. Surgical intervention was the mainstay initial treatment, the indication being either functional pNETs, or large or symptomatic nonfunctioning pNETs.
Conclusion
TSC-pNETs are rare and mostly nonfunctioning tumors with variable clinical behavior. Due to their uncertain malignant potential, we suggest that baseline pancreatic imaging should be incorporated into TSC surveillance, and we emphasize the need for heightened pNET surveillance and updated management recommendations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London NW3 2QG, UK.
- Department of Clinical Genetics, South West Thames Regional Genetics Services, St George's Hospital, London SW17 0QT, UK.
- Department of Endocrinology and Diabetes, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
- Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Hebrew University of Jerusalem Faculty of Medicine, Jerusalem 91120, Israel.
- EKPA-LAIKO, ENETS Centre of Excellence, National and Kapodistrian University of Athens, Athens 115 27, Greece.
- Tuberous Sclerosis Service, Royal United Hospitals Bath NHS Foundation Trust, Bath BA1 3NG, UK.
ORCID-Profile: Kalyan Mansukhbhai Shekhda, John Howat, Yujia Gao, Anat Bel-Ange, Simona Grozinsky-Glasberg, Gregory Kaltsas, Kai Man Alexander Ho, Aimee R Hayes, Dalvinder Mandair, Christos Toumpanakis, Efthimia Karra, Deirdre Donnelly, Elizabeth A Jones, Finbar O'Callaghan, Asheesh Sharma, Rajaventhan Srirajaskanthan, Martyn Caplin, Frances Elmslie, Ashley Grossman
Zitieren
APA
Shekhda, K. M., Howat, J., Gao, Y., Bel-Ange, A., Grozinsky-Glasberg, S., Kaltsas, G., Ho, K. M. A., Hayes, A. R., Mandair, D., Toumpanakis, C., Karra, E., Dixon, R. A., Donnelly, D., Jones, E. A., Jones, C. H., O'Callaghan, F., Sharma, A., Slaney, K., Frydman, A., …, & Grossman, A. (2026). Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review. Journal of the Endocrine Society, 10(9). https://doi.org/10.1210/jendso/bvag178
Vancouver
Shekhda KM, Howat J, Gao Y, Bel-Ange A, Grozinsky-Glasberg S, Kaltsas G, et al. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review. Journal of the Endocrine Society. 2026;10(9). doi:10.1210/jendso/bvag178
BibTeX
@article{Shekhda2026,
author = {Shekhda, Kalyan Mansukhbhai and Howat, John and Gao, Yujia and Bel-Ange, Anat and Grozinsky-Glasberg, Simona and Kaltsas, Gregory and Ho, Kai Man Alexander and Hayes, Aimee R and Mandair, Dalvinder and Toumpanakis, Christos and Karra, Efthimia and Dixon, Richard A and Donnelly, Deirdre and Jones, Elizabeth A and Jones, Colin H and O'Callaghan, Finbar and Sharma, Asheesh and Slaney, Kirsten and Frydman, Aviva and Srirajaskanthan, Rajaventhan and Kibrya, Nabil and Caplin, Martyn and Elmslie, Frances and Grossman, Ashley},
title = {Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {9},
doi = {10.1210/jendso/bvag178}
}
EUVIMED